靶向 Eva1(MPZL2)的 CAR-T 细胞的开发与优化
Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.
这些数据表明,人源化 Eva1CAR-T 在治疗多种 Eva1 阳性实体瘤方面具有有前景的治疗潜力。
67.8分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.
这些数据表明,人源化 Eva1CAR-T 在治疗多种 Eva1 阳性实体瘤方面具有有前景的治疗潜力。
Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression.
Current status of cancer genome medicine for pancreatic ductal adenocarcinoma.
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells.
Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft mod
共 5 条
MEMBER ACCOUNT
登录成功会直接打开下一页。